1
|
Partnered Excited-State Intermolecular Proton Transfer Fluorescence (P-ESIPT) Signaling for Nitrate Sensing and High-Resolution Cell-Imaging. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27165164. [PMID: 36014404 PMCID: PMC9416243 DOI: 10.3390/molecules27165164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Revised: 07/24/2022] [Accepted: 07/28/2022] [Indexed: 11/17/2022]
Abstract
Nitrite (NO2−) is a common pollutant and is widely present in the environment and in human bodies. The development of a rapid and accurate method for NO2− detection is always a very important task. Herein, we synthesized a partnered excited-state intermolecular proton transfer (ESIPT) fluorophore using the “multi-component one pot” method, and used this as a probe (ESIPT-F) for sensing NO2−. ESIPT-F exhibited bimodal emission in different solvents because of the solvent-mediated ESIPT reaction. The addition of NO2− caused an obvious change in colors and tautomeric fluorescence due to the graft of NO2− into the ESIPT-F molecules. From this basis, highly sensitive and selective analysis of NO2− was developed using tautomeric emission signaling, achieving sensitive detection of NO2− in the concentration range of 0~45 mM with a detection limit of 12.5 nM. More importantly, ESIPT-F showed the ability to anchor proteins and resulted in a recognition-driven “on-off” ESIPT process, enabling it to become a powerful tool for fluorescence imaging of proteins or protein-based subcellular organelles. MTT experimental results revealed that ESIPT-F is low cytotoxic and has good membrane permeability to cells. Thus, ESIPT-F was further employed to image the tunneling nanotube in vitro HEC-1A cells, displaying high-resolution performance.
Collapse
|
2
|
Zhang Y, Wong HS. Are mitochondria the main contributor of reactive oxygen species in cells? J Exp Biol 2021; 224:224/5/jeb221606. [PMID: 33707189 DOI: 10.1242/jeb.221606] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Physiologists often assume that mitochondria are the main producers of reactive oxygen species (ROS) in cells. Consequently, in biomedicine, mitochondria are considered as important targets for therapeutic treatments, and in evolutionary biology, they are considered as mediators of life-history tradeoffs. Surprisingly, data supporting such an assumption are lacking, at least partially due to the technical difficulties in accurately measuring the level of ROS produced by different subcellular compartments in intact cells. In this Commentary, we first review three potential reasons underlying the misassumption of mitochondrial dominance in the production of cellular ROS. We then introduce some other major sites/enzymes responsible for cellular ROS production. With the use of a recently developed cell-based assay, we further discuss the contribution of mitochondria to the total rate of ROS release in cell lines and primary cells of different species. In these cells, the contribution of mitochondria varies between cell types but mitochondria are never the main source of cellular ROS. This indicates that although mitochondria are one of the significant sources of cellular ROS, they are not necessarily the main contributor under normal conditions. Intriguingly, similar findings were also observed in cells under a variety of stressors, life-history strategies and pathological stages, in which the rates of cellular ROS production were significantly enhanced. Finally, we make recommendations for designing future studies. We hope this paper will encourage investigators to carefully consider non-mitochondrial sources of cellular ROS in their study systems or models.
Collapse
Affiliation(s)
- Yufeng Zhang
- College of Health Sciences, The University of Memphis, Memphis, TN 38152, USA
| | - Hoi Shan Wong
- Calico Life Sciences LLC, South San Francisco, CA 94080, USA
| |
Collapse
|
3
|
Maimon E, Samuni A, Goldstein S. Mechanistic insight into the catalytic inhibition by nitroxides of tyrosine oxidation and nitration. Biochim Biophys Acta Gen Subj 2019; 1863:129403. [PMID: 31356821 DOI: 10.1016/j.bbagen.2019.07.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Revised: 07/03/2019] [Accepted: 07/24/2019] [Indexed: 12/20/2022]
Abstract
BACKGROUND Nitroxide antioxidants (RNO•) protect from injuries associated with oxidative stress. Tyrosine residues in proteins are major targets for oxidizing species giving rise to irreversible cross-linking and protein nitration, but the mechanisms underlying the protective activity of RNO• on these processes are not sufficiently clear. METHODS Tyrosine oxidation by the oxoammonium cation (RN+=O) was studied by following the kinetics of RNO• formation using EPR spectroscopy. Tyrosine oxidation and nitration were investigated using the peroxidase/H2O2 system without and with nitrite. The inhibitory effect of RNO• on these processes was studied by following the kinetics of the evolved O2 and accumulation of tyrosine oxidation and nitration products. RESULTS Tyrosine ion is readily oxidized by RN+=O, and the equilibrium constant of this reaction depends on RNO• structure and reduction potential. RNO• catalytically inhibits tyrosine oxidation and nitration since it scavenges both tyrosyl and •NO2 radicals while recycling through RN+=O reduction by H2O2, tyrosine and nitrite. The inhibitory effect of nitroxide on tyrosine oxidation and nitration increases as its reduction potential decreases where the 6-membered ring nitroxides are better catalysts than the 5-membered ones. CONCLUSIONS Nitroxides catalytically inhibit tyrosine oxidation and nitration. The proposed reaction mechanism adequately fits the results explaining the dependence of the nitroxide inhibitory effect on its reduction potential and on the concentrations of the reducing species present in the system. GENERAL SIGNIFICANCE Nitroxides protect against both oxidative and nitrative damage. The proposed reaction mechanism further emphasizes the role of the reducing environment to the efficacy of these catalysts.
Collapse
Affiliation(s)
- Eric Maimon
- Nuclear Research Centre Negev and Chemistry Department, Ben-Gurion University, Beer-Sheva 84105, Israel
| | - Amram Samuni
- Institute of Medical Research, Israel-Canada Medical School, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Sara Goldstein
- Institute of Chemistry, The Accelerator Laboratory, the Hebrew University of Jerusalem, Jerusalem 91904, Israel.
| |
Collapse
|
6
|
Samuni A, Maimon E, Goldstein S. Mechanism of HRP-catalyzed nitrite oxidation by H 2O 2 revisited: Effect of nitroxides on enzyme inactivation and its catalytic activity. Free Radic Biol Med 2017; 108:832-839. [PMID: 28495446 DOI: 10.1016/j.freeradbiomed.2017.05.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2017] [Revised: 05/01/2017] [Accepted: 05/07/2017] [Indexed: 10/19/2022]
Abstract
The peroxidative activity of horseradish peroxidase (HRP) undergoes progressive inactivation while catalyzing the oxidation of nitrite by H2O2. The extent of inactivation increases as the pH increases, [nitrite] decreases or [H2O2] increases, and is accompanied by a loss of the Soret peak of HRP along with yellow-greenish coloration of the solution. HRP-catalyzed nitrite oxidation by H2O2 involves not only the formation of compounds I and II as transient heme species, but also compound III, all of which in turn, oxidize nitrite yielding •NO2. The rate constant of nitrite oxidation by compound III is at least 10-fold higher than that by compound II, which is also reducible by •NO2 where its reduction by nitrite is the rate-determining step of the catalytic cycle. The extent of the loss of the Soret peak of HRP is lower than the loss of its peroxidative activity implying that deterioration of the heme moiety leading to iron release only partially contributes toward heme inactivation. Cyclic stable nitroxide radicals, such as 2,2,6,6-tetramethyl-piperidine-N-oxyl (TPO), 4-OH-TPO and 4-NH2-TPO at µM concentrations detoxify •NO2 thus protecting HRP against inactivation mediated by this radical. Hence, HRP inactivation proceeds via nitration of the porphyrin ring most probably through compound I reaction with •NO2, which partially leads to deterioration of the heme moiety. The nitroxide acts catalytically since its oxidation by •NO2 yields the respective oxoammonium cation, which is readily reduced back to the nitroxide by H2O2, superoxide ion radical, and nitrite. In addition, the nitroxide catalytically inhibits tyrosine nitration mediated by HRP/H2O2/nitrite reactions system as it efficiently competes with tyrosyl radical for •NO2. The inhibition by nitroxides of tyrosine nitration is demonstrated also in the case of microperoxidase (MP-11) and cytochrome c revealing an additional role played by nitroxide antioxidants.
Collapse
Affiliation(s)
- Amram Samuni
- Institute of Medical Research Israel-Canada, Medical School, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Eric Maimon
- Nuclear Research Centre Negev, Be'er Sheva, Israel
| | - Sara Goldstein
- Institute of Chemistry, The Accelerator Laboratory, the Hebrew University of Jerusalem, Jerusalem 91904, Israel.
| |
Collapse
|
7
|
Zou X, Ratti BA, O'Brien JG, Lautenschlager SO, Gius DR, Bonini MG, Zhu Y. Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox signaling? J Bioenerg Biomembr 2017; 49:325-333. [PMID: 28616679 DOI: 10.1007/s10863-017-9718-8] [Citation(s) in RCA: 67] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2016] [Accepted: 05/29/2017] [Indexed: 02/06/2023]
Abstract
It is becoming increasingly clear that mitochondria drive cellular functions and in vivo phenotypes by directing the production rate and abundance of metabolites that are proposed to function as signaling molecules (Chandel 2015; Selak et al. 2005; Etchegaray and Mostoslavsky 2016). Many of these metabolites are intermediates that make up cellular metabolism, part of which occur in mitochondria (i.e. the TCA and urea cycles), while others are produced "on demand" mainly in response to alterations in the microenvironment in order to participate in the activation of acute adaptive responses (Mills et al. 2016; Go et al. 2010). Reactive oxygen species (ROS) are well suited for the purpose of executing rapid and transient signaling due to their short lived nature (Bae et al. 2011). Hydrogen peroxide (H2O2), in particular, possesses important characteristics including diffusibility and faster reactivity with specific residues such as methionine, cysteine and selenocysteine (Bonini et al. 2014). Therefore, it is reasonable to propose that H2O2 functions as a relatively specific redox signaling molecule. Even though it is now established that mtH2O2 is indispensable, at least for hypoxic adaptation and energetic and/or metabolic homeostasis (Hamanaka et al. 2016; Guzy et al. 2005), the question of how H2O2 is produced and regulated in the mitochondria is only partially answered. In this review, some roles of this indispensable signaling molecule in driving cellular metabolism will be discussed. In addition, we will discuss how H2O2 formation in mitochondria depends on and is controlled by MnSOD. Finally, we will conclude this manuscript by highlighting why a better understanding of redox hubs in the mitochondria will likely lead to new and improved therapeutics of a number of diseases, including cancer.
Collapse
Affiliation(s)
- Xianghui Zou
- Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Room 3-250, Lurie Research Building, 303 East Superior, Chicago, IL, 60611, USA.,Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Driskill Graduate Program in Life Science, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Bianca A Ratti
- Programa de Biociencias Aplicadas a Farmacia (PBF), Universidade Estadual de Maringa, Maringa, PR, Brazil.,Departments of Medicine and Pathology, University of Illinois College of Medicine in Chicago, Chicago, IL, USA
| | - Joseph Gerald O'Brien
- Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Room 3-250, Lurie Research Building, 303 East Superior, Chicago, IL, 60611, USA.,Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Sueli O Lautenschlager
- Programa de Biociencias Aplicadas a Farmacia (PBF), Universidade Estadual de Maringa, Maringa, PR, Brazil
| | - David R Gius
- Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Room 3-250, Lurie Research Building, 303 East Superior, Chicago, IL, 60611, USA.,Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Marcelo G Bonini
- Departments of Medicine and Pathology, University of Illinois College of Medicine in Chicago, Chicago, IL, USA
| | - Yueming Zhu
- Department of Radiation Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Room 3-250, Lurie Research Building, 303 East Superior, Chicago, IL, 60611, USA. .,Department of Pharmacology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
| |
Collapse
|
8
|
Samuni A, Maimon E, Goldstein S. Nitroxides protect horseradish peroxidase from H 2O 2-induced inactivation and modulate its catalase-like activity. Biochim Biophys Acta Gen Subj 2017; 1861:2060-2069. [PMID: 28365302 DOI: 10.1016/j.bbagen.2017.03.021] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Revised: 03/05/2017] [Accepted: 03/20/2017] [Indexed: 11/24/2022]
Abstract
BACKGROUND Horseradish peroxidase (HRP) catalyzes H2O2 dismutation while undergoing heme inactivation. The mechanism underlying this process has not been fully elucidated. The effects of nitroxides, which protect metmyoglobin and methemoglobin against H2O2-induced inactivation, have been investigated. METHODS HRP reaction with H2O2 was studied by following H2O2 depletion, O2 evolution and heme spectral changes. Nitroxide concentration was followed by EPR spectroscopy, and its reactions with the oxidized heme species were studied using stopped-flow. RESULTS Nitroxide protects HRP against H2O2-induced inactivation. The rate of H2O2 dismutation in the presence of nitroxide obeys zero-order kinetics and increases as [nitroxide] increases. Nitroxide acts catalytically since its oxidized form is readily reduced to the nitroxide mainly by H2O2. The nitroxide efficacy follows the order 2,2,6,6-tetramethyl-piperidine-N-oxyl (TPO)>4-OH-TPO>3-carbamoyl proxyl>4-oxo-TPO, which correlates with the order of the rate constants of nitroxide reactions with compounds I, II, and III. CONCLUSIONS Nitroxide catalytically protects HRP against inactivation induced by H2O2 while modulating its catalase-like activity. The protective role of nitroxide at μM concentrations is attributed to its efficient oxidation by P940, which is the precursor of the inactivated form P670. Modeling the dismutation kinetics in the presence of nitroxide adequately fits the experimental data. In the absence of nitroxide the simulation fits the observed kinetics only if it does not include the formation of a Michaelis-Menten complex. GENERAL SIGNIFICANCE Nitroxides catalytically protect heme proteins against inactivation induced by H2O2 revealing an additional role played by nitroxide antioxidants in vivo.
Collapse
Affiliation(s)
- Amram Samuni
- Institute of Medical Research Israel-Canada, Medical School, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
| | - Eric Maimon
- Nuclear Research Centre Negev, Beer Sheva, Israel
| | - Sara Goldstein
- Institute of Chemistry, The Accelerator Laboratory, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
| |
Collapse
|